Progress in central nervous system lymphomas. Read more about Progress in central nervous system lymphomas.
Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP). Read more about Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
X chromosome-wide association study of follicular lymphoma. Read more about X chromosome-wide association study of follicular lymphoma.
Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation. Read more about Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation.
Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Read more about Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes.
DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups. Read more about DNA methylation analysis of ALOX12 and GSTM1 in acute myeloid leukaemia identifies prognostically significant groups.
Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study. Read more about Racial patterns of extranodal natural killer/T-cell lymphoma, nasal type, in California: a population-based study.
The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*. Read more about The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation*.
Epigenetic silencing of MIR203 in multiple myeloma. Read more about Epigenetic silencing of MIR203 in multiple myeloma.
Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Read more about Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.
